Insider · SEC Form 4 · 10% Owner
Forbion Growth Opportunities Fund III Cooperatief U.A.
In the 12 months to Nov 19, 2026, on the open market: bought $64.8M of BRVE. Filed 0 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- BRVEBought: Braveheart Bio, Inc. $64.8M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G
Other Form 4 entries
Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.
- BRVE: conversion (code C), 2 entries, Aug 7, 2026
- Code C
- A conversion of a derivative security, such as preferred stock or units, into shares.
Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.